The effects of pharmacological treatment on obstetrical outcome are not well known and some of these agents are considered teratogenic. Thus, the decision to treat pregnant patients with psychotropic agents requires solving an ethical dilemma. Risk-benefit decisions should be made while considering both the risk of relapse of bipolar disorder and its morbidity, and the risk of fetal exposure to psychotropic medications. Moreover, the risk of recurrence increases dramatically in the postpartum period. It is also well known that all of the psychotropic medications that are studied before are passed thorough to the breast milk, therefore while prescribing for a breastfeeding woman the effects on infants should be considered. In this REVIEW , the use of psychotropic drugs in patients with bipolar disorder in pregnancy and in postpartum period are represented regarding to some practical applications.
The effects of pharmacological treatment on obstetrical outcome are not well known and some of these agents are considered teratogenic. Thus, the decision to treat pregnant patients with psychotropic agents requires solving an ethical dilemma. Risk-benefit decisions should be made while considering both the risk of recurrence of bipolar disorder and its morbidity, and the risk of fetal exposure to psychotropic medications. Moreover, the risk of recurrence increases dramatically in the postpartum period. It is also well known that all of the psychotropic medications that are studied before are passed thoroughly to the breast milk, therefore while prescribing for a breastfeeding woman the effects on infants should be considered. In this REVIEW, the use of psychotropic drugs in patients with bipolar disorder in pregnancy and in postpartum period are represented regarding to some practical applications.
Alan : Sağlık Bilimleri
Dergi Türü : Ulusal
Benzer Makaleler | Yazar | # |
---|
Makale | Yazar | # |
---|